| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nutthasirikul, N. Limpaiboon, T. Leelayuwat, C. Patrakitkomjorn, S. Jearanaikoon, P. |
2013 | ||||
| 2. | Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma. | Nichapavee Nutthasirikul Temduang Limpaiboon Chanvit Leelayuwat Siriporn Patrakitkomjorn Patcharee Jearanaikoon |
2013 | ||||
| 3. | Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. | Nichapavee Nutthasirikul Chariya Hahnvajanawong Anchalee Techasen Temduang Limpaiboon Chanvit Leelayuwat Siri Chau-In Patcharee Jearanaikoon |
2015 | Count | 1 | 2 | 2 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nutthasirikul, N. Limpaiboon, T. Leelayuwat, C. Patrakitkomjorn, S. Jearanaikoon, P. |
2013 |
International Journal of Oncology 4 (42), pp. 1181-1188 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma. | Nutthasirikul, N Limpaiboon, T Leelayuwat, C Patrakitkomjorn, S Jearanaikoon, P |
2013 |
International journal of oncology 4 (42), pp. 1181-8 |
|
| 2. | Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. | Nutthasirikul, N Hahnvajanawong, C Techasen, A Limpaiboon, T Leelayuwat, C Chau-In, S Jearanaikoon, P |
2015 |
International journal of oncology (), pp. |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Ratio disruption of the Delta 133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nichapavee Nutthasirikul Temduang Limpaiboon Chanvit Leelayuwat Siriporn Patrakitkomjorn Patcharee Jearanaikoon |
2013 |
INTERNATIONAL JOURNAL OF ONCOLOGY 4.0 (42.0), pp. 1181.0-1188.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 2. | Targeting the Delta 133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells | Nichapavee Nutthasirikul Chariya Hahnvajanawong Anchalee Techasen Temduang Limpaiboon Chanvit Leelayuwat Siri Chau-In Patcharee Jearanaikoon |
2015 |
INTERNATIONAL JOURNAL OF ONCOLOGY 6.0 (47.0), pp. 2153.0-2164.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|